日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
World
Home / World / Europe

EU looks into second jab linked to blood clots

China Daily | Updated: 2021-04-12 09:53
Share
Share - WeChat
Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Johnson & Johnson logo in this illustration taken on Oct 31, 2020. [Photo/Agencies]

PARIS-Europe's stuttering vaccine drive faced multiple hurdles as EU regulators said on Friday they were reviewing side effects of the Johnson & Johnson vaccine.

As the continent continues to reel from constant rows over AstraZeneca's vaccine, whose use has been limited in some countries because of blood clots, the EU's medicine regulator announced it would be investigating a second vaccine over similar concerns.

The European Medicines Agency said four "serious cases" of unusual blood clots had been reported, one fatal, with the J&J vaccine, which uses technology similar to that used in the AstraZeneca one.

The US drugs regulator said it had not found a causal link between the J&J vaccine and blood clots, but that its investigation was continuing after "a few individuals" suffered complications.

The company issued a statement saying: "At present, no clear causal relationship has been established between these rare events and the Janssen COVID-19 vaccine," referring to J&J's European subsidiary.

Both vaccines are approved for use in the European Union but the J&J vaccine has yet to be introduced, and various EU countries have stopped or limited the use of the AstraZeneca vaccine.

Much of the world is still in the clutches of the pandemic, which has killed 2.9 million people, and across Europe populations are facing some of the world's toughest antivirus measures, yet the virus refuses to be curbed.

Italy recorded 718 deaths on Friday, its highest number in months, but health officials said the spike from 487 a day earlier was due to a backlog of deaths being reported in Sicily.

The country's death toll has remained stubbornly high as the vaccination campaign for the most vulnerable population has lagged.

The President of Italy's National Health Institute, Silvio Brusaferro, said the new contagion that was first detected in the United Kingdom has reached a plateau in Italy, with 18,938 new cases on Friday. Much of the country remains on partial lockdown.

Germany's central government has tried hard to defeat the virus through restrictions on movement and commerce, but several states have torpedoed the strategy by refusing to go along with the proposals.

Now Berlin is changing the rules to gather more centralized power.

The proposed adjustments are likely to usher in curfews and some school closures in especially hard-hit areas.

The number of confirmed cases in Germany rose by 17,855 to 2,998,268, according to figures on Sunday from the Robert Koch Institute for infectious diseases.

All of France is subjected to restrictions of some form, and more than 10 million people in the country have received the vaccine.

Doubts on efficacy

But the country has repeatedly changed the rules on AstraZeneca's vaccine, first over doubts about its efficacy, then over fears that it could be linked to blood clots.

On Friday it did so again, with Health Minister Olivier Veran saying citizens under 55 who had been given a first shot with AstraZeneca would be given a different vaccine for their second dose.

Elsewhere in the world, supply problems are also hampering vaccination efforts.

India, one of the world's leading vaccine makers, is suffering its own problems with vaccination in Maharashtra, home to more than 100 million people, and the economic hub Mumbai.

"Most hospitals in Mumbai will exhaust their supplies by the end of the day," Mangala Gomare, who oversees the city's vaccination program, said on Friday.

Agencies via Xinhua

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 国产精品入口麻豆 | h小视频在线观看网 | 国产精品冒白浆免费视频 | 欧美日一区二区三区 | 久久久久久久国产精品影院 | 成人免费网站www网站高清 | 极品xxxx欧美一区二区 | 午夜免费电影院 | 久久久久久9 | 色香首页 | 99国产在线精品视频 | 污污视频免费网站 | 精品人妻无码一区二区三区手机板 | 国产精品尤物在线观看一区 | 久久精品一本到99热免费 | 91亚洲国产| 涩涩色综合亚洲悠悠色 | 成年人在线观看视频 | 久久中文字幕视频 | 久草手机视频在线 | 日韩欧美亚洲一区 | 亚洲九九| 免费黄色日韩电影 | 欧美a在线看| 啊啊啊好紧好爽 | 狠狠干91 | 欧美日韩国产手机在线观看视频 | 国产精品69久久久久水密桃 | 精品一区二区三区三区 | 亚洲第一区精品观看 | 亚洲热综合 | 日韩一区电影 | 人人澡人人澡人人看添欧美 | 久久99精品国产 | 素人视频免费观看 | 国产精品久久久久久久久久久久 | 日韩免费视频网站 | 黄在线观看在线播放720p | 亚洲国产成人av好男人在线观看 | 日本在线免费观看视频 | 性强烈欧美一级毛片 |